Welcome to Hege Edvardsen's project group:

Response and Side Effects of Cancer Therapy

Current projects

Radiation induced fibrosis

Cancer related fatigue

Genomic studies of therapy response - focusing on reactive oxygen species

Projects are open for master students.

Funding:

The projects are supported with funding from both internal and external foundations and trusts

Eckbo's legat til fremme av folkehelsen
Familien Blix fond
Astri og Birger Thorsteds legat
Olav Raagholt og Gerd Meidel Raagholts stiftelse for forskning
Ivar, Ragna og Morten Holes Legat Til Fremme Av Kreftforskningen i Norge

Group contact information:
Hege Edvardsen, Department of Genetics, Institute for Cancer Research
OUS Radiumhospitalet, Montebello, 0310 Oslo, Norway
Phone +47 22 78 13 80 Fax: +47 22 78 13 95, Switchboard: +47 22 93 40 00 Email: hege.edvardsen(at)rr-research.no

[179 visits]

Go back

Print this page

E-mail this page

News & events

Gordon Research Conference awards to Haugsten and Zakrzewska
May 22, 2012

Institute Seminar - Wednesday May 23rd
Giske Ursin
May 22, 2012

Understanding breast cancer
Landscape of cancer genes and mutational processes in breast cancer
May 21, 2012

Untangling the development of breast cancer
Researchers announce the first comprehensive genome studies of the evolution of 21 breast cancers
May 18, 2012

Presentation of prestigious research project
Actionable Targets in Cancer Metastasis (MetAction) – from Bed to Bench to Byte to Bedside
May 16, 2012

More news

Latest publications:

Hege Edvardsen

Kaveh F, Edvardsen H, Børresen-Dale AL, N Kristensen V, Solvang HK (2011)
Allele-specific disparity in breast cancer
BMC Med Genomics, 4, 85
PubMed 22188678

Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H (2011)
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
Brain Behav Immun, 25 (7), 1376-83
PubMed 21496483

Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS et al. (2011)
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians
Cancer Cell, 19 (2), 273-82
PubMed 21316605

More publications